417 related articles for article (PubMed ID: 28416205)
1. The link between schizophrenia and substance use disorder: A unifying hypothesis.
Khokhar JY; Dwiel LL; Henricks AM; Doucette WT; Green AI
Schizophr Res; 2018 Apr; 194():78-85. PubMed ID: 28416205
[TBL] [Abstract][Full Text] [Related]
2. Alcohol dependence and schizophrenia: what are the interrelationships?
Soyka M
Alcohol Alcohol Suppl; 1994; 2():473-8. PubMed ID: 8974370
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiology, etiology and treatment of patients with psychosis and co-morbid substance use disorder].
Moggi F
Ther Umsch; 2018 Jun; 75(1):37-43. PubMed ID: 29909760
[TBL] [Abstract][Full Text] [Related]
4. [Negative symptoms in schizophrenia and substance-related disorders].
Simon N; Belzeaux R; Adida M; Azorin JM
Encephale; 2015 Dec; 41(6 Suppl 1):6S27-31. PubMed ID: 26776388
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for schizophrenia and co-occurring substance use disorders.
Green AI
Neurotox Res; 2007 Jan; 11(1):33-40. PubMed ID: 17449446
[TBL] [Abstract][Full Text] [Related]
6. Addiction and schizophrenia.
Batel P
Eur Psychiatry; 2000 Mar; 15(2):115-22. PubMed ID: 10881208
[TBL] [Abstract][Full Text] [Related]
7. Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?
Roth RM; Brunette MF; Green AI
Curr Psychiatry Rep; 2005 Aug; 7(4):283-91. PubMed ID: 16098282
[TBL] [Abstract][Full Text] [Related]
8. [Dual diagnosis psychosis and substance use disorders in adolescents--part 1].
Meister K; Burlon M; Rietschel L; Gouzoulis-Mayfrank E; Bock T; Lambert M
Fortschr Neurol Psychiatr; 2010 Feb; 78(2):81-9. PubMed ID: 20146152
[TBL] [Abstract][Full Text] [Related]
9. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
[TBL] [Abstract][Full Text] [Related]
10. [Homicide, schizophrenia and substance abuse: a complex interaction].
Richard-Devantoy S; Bouyer-Richard AI; Jollant F; Mondoloni A; Voyer M; Senon JL
Rev Epidemiol Sante Publique; 2013 Aug; 61(4):339-50. PubMed ID: 23816066
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.
Faridi K; Pawliuk N; King S; Joober R; Malla AK
Schizophr Res; 2009 Oct; 114(1-3):57-63. PubMed ID: 19666214
[TBL] [Abstract][Full Text] [Related]
12. [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia].
Ameller A; Gorwood P
Encephale; 2015 Apr; 41(2):174-83. PubMed ID: 25838239
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Course of Clients With Co-occurring Schizophrenia-Spectrum and Substance Use Disorders in Urban Mental Health Centers: A 7-Year Prospective Study.
Drake RE; Luciano AE; Mueser KT; Covell NH; Essock SM; Xie H; McHugo GJ
Schizophr Bull; 2016 Jan; 42(1):202-11. PubMed ID: 26294706
[TBL] [Abstract][Full Text] [Related]
14. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
Potvin S; Stip E; Roy JY
Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
[TBL] [Abstract][Full Text] [Related]
15. Substance use disorders in schizophrenia: review, integration, and a proposed model.
Blanchard JJ; Brown SA; Horan WP; Sherwood AR
Clin Psychol Rev; 2000 Mar; 20(2):207-34. PubMed ID: 10721498
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder.
Miles H; Johnson S; Amponsah-Afuwape S; Finch E; Leese M; Thornicroft G
Psychiatr Serv; 2003 Apr; 54(4):554-61. PubMed ID: 12663845
[TBL] [Abstract][Full Text] [Related]
17. Demographic and clinical correlates of substance use disorders in first episode psychosis.
Brunette MF; Mueser KT; Babbin S; Meyer-Kalos P; Rosenheck R; Correll CU; Cather C; Robinson DG; Schooler NR; Penn DL; Addington J; Estroff SE; Gottlieb J; Glynn SM; Marcy P; Robinson J; Kane JM
Schizophr Res; 2018 Apr; 194():4-12. PubMed ID: 28697856
[TBL] [Abstract][Full Text] [Related]
18. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.
Blum K; Oscar-Berman M; Badgaiyan RD; Palomo T; Gold MS
Med Hypotheses; 2014 May; 82(5):606-14. PubMed ID: 24636783
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.
Weibell MA; Hegelstad WTV; Auestad B; Bramness J; Evensen J; Haahr U; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan T; McGorry P; Friis S
Schizophr Bull; 2017 Jul; 43(4):843-851. PubMed ID: 28199703
[TBL] [Abstract][Full Text] [Related]
20. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
